Background In this single-institution case-control study, we identified risk factors associated with inflammatory breast cancer (IBC) subtypes based on staining of estrogen receptor (ER), progesterone receptor (PR) and expression of human epidermal growth factor 2 (HER2neu) to determine distinct etiologic pathways. Methods We identified 224 women with IBC and 396 cancer-free women seen at the MD Anderson Cancer Center. Multinomial logistic regression was used to estimate odds ratios (ORs) and 95 % confidence intervals (CIs) for associations between breast cancer risk factors and the IBC tumor subtypes: luminal (ER? and/or PR?/HER2-neu-), HER2neu? (any ER and PR, HER2neu?), and triple-negative (ER-/PR-/HER2neu-). Results In multivariable analysis, compared with women age C26 at first pregnancy, women age \26 had a higher risk of triple-negative IBC (OR 3.32, 95% CI 1.37-8.05).
Introduction
Inflammatory breast cancer (IBC) is rare, accounting for roughly 2.5 % of all invasive breast cancers; however, this percentage may be higher because of variability in the definitions of IBC [1] . According to data from the Surveillance, Epidemiology, and End Results (SEER) Program, the incidence rate of IBC increased from 2.0 (per 100,000 woman-years) between 1988 and 1990 to 2.5 between 1997 and 1999 [1, 2] . IBC is the most lethal form of breast cancer, and the median survival time from 1988 through 2000 was 2.9 years [1] . Improvements in survival have been noted recently with the introduction of trastuzumab-based systemic therapy and the use of multidisciplinary treatment & Abenaa M. Brewster abrewster@mdanderson.org [3, 4] . However, despite these advances in adjuvant treatment, many women every year die from IBC, highlighting the importance of identifying risk factors associated with IBC that may be targeted for disease prevention. Breast cancer is a heterogeneous disease, defined by gene expression profiling into four distinct molecular subtypes that can be approximated by estrogen receptor (ER), progesterone receptor (PR), and HER2neu [5, 6] : luminal/ER?, basal-like/ ER-/PR-/HER2neu-, Her2-enriched/HER2neu?, and unclassified. Van Laere et al. [7] showed using three distinct gene expression datasets obtained through the World IBC Consortium, that the molecular subtypes described in non-IBC are detectable in IBC, albeit with a different frequency. To date, risk factors for IBC that have been identified from a small number of case-control and case-case studies include long duration of breast-feeding, young age at first birth, and high body mass index (BMI) C25 kg/m 2 [8] [9] [10] . Whether risk factors for IBC differ according to molecular or clinically defined tumor subtypes has not been well studied. Schairer et al. [10] used the breast cancer surveillance consortium database to evaluate the risk factors for ER? compared to ER-IBC and found that older age at first birth was associated with a reduced risk of ER-IBC. Higher BMI was associated with an increased risk of both ER? and ER-IBC, and the association between BMI and IBC risk did not vary by menopausal status [10] . Some of the limitations of the study were the lack of information on additional risk factors such as breast-feeding and the triple-negative and HER2neu? subtypes were not accounted for in the analysis.
Prior epidemiologic studies have demonstrated varying risk factor associations for the ER? and triple-negative subtypes of non-IBC that may have significant implications for prevention [11] [12] [13] [14] [15] . For example, absent or short duration of breast-feeding has been consistently associated with a higher risk of triple-negative non-IBC compared with the luminal A or ER? defined subtypes of non-IBC [12, 13, 16] . Since the triple-negative subtype is overrepresented among IBC compared to non-IBC [7] , identifying the risk factors for this aggressive tumor subtype and others is relevant for investigating biological mechanisms underlying the etiology of IBC and for developing strategies for subtype-specific breast cancer prevention [1, 17] .
We conducted a large hospital-based case-control study of women seen at the University of Texas MD Anderson Cancer Center to comprehensively examine the risk factors associated with IBC and according to the following tumor subtypes: luminal (ER? and/or PR?, HER2neu-), HER2neu? (any ER/PR, HER2neu?), and triple-negative (ER-, PR-, HER2neu-). We hypothesized that, like non-IBC, distinct epidemiological risk factors would be associated with each of the clinical subtypes, supporting the concept that IBC subtypes have heterogeneous etiology.
Materials and methods

Patient population
Cases and controls were patients seen at the MD Anderson Cancer Center. This analysis included 224 patients with confirmed IBC according to the World IBC Consortium consensus case definition [18] or the American Joint Committee on Cancer (AJCC) criteria [19] . The minimal criteria for the diagnosis of IBC that was recommended at the World IBC Consortium consensus meeting held in December 2008 included the rapid onset of breast erythema (occupying at least one-third of the breast), edema and/or peau d'orange and/or warm breast, with or without an underlying palpable mass with duration of symptoms of no more than 6 months. Prior to December 2008, IBC cases were defined using the AJCC criteria as ''a clinicopathological entity characterized by diffuse erythema and edema of the breast, often without an underlying palpable mass.'' Since 2004, all newly diagnosed women with IBC receiving treatment at the MD Anderson Morgan Welch IBC clinic are invited to participate in a multicentered IBC registry. Patients are asked to complete an in-person interviewer-administered questionnaire containing detailed information on lifestyle and breast cancer risk factors at the time of recruitment. The median time from diagnosis to completion of the interviewer-administered questionnaire for the IBC cases was 19 days. For this study, we included a subset of 224 IBC cases from the registry who were aged C18 years at diagnosis, resided in the USA (62 % were Texan residents), were diagnosed between 2004 and 2012, and had no prior history of cancer except for nonmelanoma skin cancer or cervical cancer in situ.
Controls were 396 healthy women undergoing routine screening mammography at the MD Anderson Cancer Center Cancer Prevention Center who were recruited between June 2005 and January 2006 for a non-IBC casecontrol study that was conducted to identify genetic changes in candidate genes associated with the development of invasive breast cancer. The controls were consecutively screened for eligibility at the time of their clinic appointment in the cancer prevention center and approached for participation. The inclusion criteria for the controls enrolled on the parent study were Caucasian, age C18 years, resident in the state of Texas, and no prior history of cancer except for nonmelanoma skin cancer or cervical cancer in situ. All controls completed an in-person interviewer-administered questionnaire containing information on lifestyle and breast cancer risk factors. For this study, we included all 396 controls who were recruited for the parent non-IBC case-control study. Missing or incomplete information in the questionnaires administered to the IBC cases and controls could be obtained from the medical record.
The variables selected for inclusion in the study were similarly worded between the different questionnaires that were administered to the IBC cases and controls. Body weight and height at the time of the interview were collected from the medical record, and body mass index (BMI) was calculated as body weight (kg)/height (m) 2 . Categories for BMI were based on National Heart, Lung, and Blood Institute cut-points (\25 kg/m 2 normal or underweight, C25 kg/m 2 overweight and obese). Women who had smoked at least 100 cigarettes in their lifetime, who had children, or who had breast-fed children were classified as ''ever'' in terms of smoking history, parity, and breast-feeding history, respectively. The breast-feeding and age at first pregnancy comparisons were restricted to parous women. Participants provided written informed consent to participate using documents approved by the MD Anderson Cancer Center institutional review board.
Statistical analysis
Pearson Chi-square tests were used to test for distribution differences between risk factors for IBC cases and controls. Multinomial logistic regression was used to estimate odds ratios (ORs) as a measure of the association between potential risk factors and tumor subtypes, with 95% CIs. Tumor subtypes were classified as luminal (ER? and/or PR?, HER2neu-), HER2neu? (any ER or PR, HER2neu?) or triple-negative (ER-, PR-, HER2neu-), and the control subjects were used as the comparison group. Variables with a p value threshold of 0.25 in the univariate analysis were included in the multivariable model, and a stepwise selection procedure was used to determine the most parsimonious multivariable model with a p value threshold of 0.05. The risk factors collected in the questionnaires and included in the multivariable model were age, age at menarche, menopausal status, number of children, number of abortions or miscarriages, age at first pregnancy, breastfeeding history, BMI, smoking history, and breast cancer family history. p values to test for heterogeneity of the ORs between risk factors and IBC subtypes were obtained using logistic regression for the comparison of triple-negative and HER2neu? IBC subtypes to the luminal IBC subtype. To evaluate for interaction between BMI, menopausal status and risk of IBC subtype, likelihood ratio tests were used to calculate p values comparing models with main effects to models with main effects plus relevant interaction terms. All P values were reported at two-sided test with an alpha level of 0.05. Statistical analyses were performed with Stata 12.0 (StataCorp LP, College Station, TX).
Results
Distribution of descriptive statistics
The distribution of characteristics of reproduction history and lifestyle risk factors for IBC cases and controls are presented in Table 1 . Among the 224 IBC cases, 64 (29 %) had triple-negative disease, 85 (38 %) had HER2neu? disease, and 75 (33 %) had luminal disease. The mean ages were similar between the IBC cases and controls. Reproductive factors found to be associated with IBC included parity (p \ 0.01), increasing number of children (p \ 0.01), age \26 at first pregnancy (p \ 0.01), and lack of breast-feeding (p \ 0.01). Lifestyle factors associated with IBC included overweight or obese status (p \ 0.01) and a history of smoking (p = 0.02). IBC cases were less likely to have had a family history of breast cancer compared with controls (p \ 0.01) although it should be noted that 9.8 % of cases were missing family history information compared to 0 % of controls.
Univariable analysis by IBC tumor subtypes
The age-adjusted associations between reproductive and lifestyle risk factors and the three IBC subtypes (triplenegative, HER2neu?, and luminal) compared with controls are presented in Table 2 . Parity was positively associated with an increased risk of HER2neu? IBC (OR 3.17; 95% CI 1.48-6.80). Women who were aged \26 at first pregnancy compared to those aged C26 were at increased risk of all IBC subtypes, with the strongest association observed for triple-negative IBC (OR 3.90; 95% CI 1.93-7.99). A history of breast-feeding was associated with a lower risk of both triple-negative IBC (OR 0.35; 95% CI 0.19-0.64) and luminal IBC (OR 0.36; 95% CI 0.20-0.66). Having a BMI C25 kg/m 2 was positively associated with all subtypes of IBC, with the strongest association for HER2neu? IBC (OR 4.95; 95% CI 2.72-8.98). Having a family history of breast cancer among first-degree relatives was associated with a decreased risk of all three IBC subtypes (p \ 0.01), and a history of smoking was associated with an increased risk of HER2neu? IBC (OR 1.84; 95% CI 1.14-2.96).
Multivariable analysis by IBC tumor subtypes
The multivariate associations between reproductive and lifestyle risk factors and the three IBC subtypes (triplenegative, HER2neu?, and luminal) compared with controls are presented in Table 3 . In addition, p values are shown for the comparisons between risk factors and triple-negative and HER2neu? IBC subtypes with luminal IBC as the referent IBC inflammatory breast cancer, BMI body mass index, CI confidence interval * Odds ratio and 95% CI were obtained from case-control comparison using multinomial logistic regression analysis adjusted for age 
Discussion
To our knowledge, this is the largest hospital-based casecontrol study of IBC from a single institution conducted to date. We identified distinct epidemiologic risk factors that were associated with specific subtypes of IBC, specifically age at first pregnancy, a history of smoking, and breastfeeding. Being overweight or obese was positively associated with risk of the three IBC tumor subtypes. Our results suggest that similar to non-IBC, established modifiable breast cancer risk factors may be differentially associated with IBC subtypes and could be essential for subtype-specific risk assessment and disease prevention.
Risk factors for IBC have generally been found to be similar to those for triple-negative non-IBC tumors [8, 10] . Specifically, younger age at diagnosis, younger age at the birth of the first child, and high BMI have been linked with increased risk in both populations [8, 10, 12] . Similarly, we found that women with triple-negative IBC were younger at first pregnancy than controls. In a previous study at MD Anderson, 68 patients with IBC were compared with 134 patients with cancer at other anatomic sites, and the BMI was found to be significantly higher in the patients with the IBC [8] . Similar results were also reported in a larger study of the breast cancer surveillance consortium database, with IBC inflammatory breast cancer, BMI body mass index, CI confidence interval * Odds ratio and 95% CI were obtained from case-control comparison using stepwise multinomial logistic regression analysis adjusted for age at menarche, menopausal status, number of children, age at first pregnancy, breast-feeding history, BMI, smoking history, and breast cancer family history p values for comparisons of the subtypes HER2neu? and triple-negative IBC compared to luminal IBC using logistic regression adjusted for age at menarche, menopausal status, number of children, age at first pregnancy, breast-feeding history, BMI, smoking history, and breast cancer family history higher BMI found to be associated with increased IBC risk regardless of menopausal status or ER expression [10] . One possible hypothesis for the relationship between IBC and higher BMI, regardless of menopausal status, is that obese women may have chronically inflamed breast tissue, and increased numbers of macrophages, that could increase susceptibility to the development of IBC [20, 21] . In support of this hypothesis, gene expression profiles from IBC tumors compared with those of non-IBC tumors have identified an expression signature characterized by activated inflammation and immune-related genes that is seen more often in IBC tumors than in non-IBC tumors [7] .
A finding unique to our study was the association between ever breast-feeding and decreased risk of both the triple-negative and ER? IBC subtypes. Le et al. [9] investigated the relationship between breast-feeding and IBC among IBC cases and non-IBC breast cancer controls and reported that longer duration of breast-feeding was associated with an increased risk of IBC. However, that study had significant bias in that both the non-IBC cancer controls and the IBC cases were from different countries of origin, and therefore, the association may have reflected differences in the prevalence of breast-feeding between regions. Our finding that breast-feeding influences IBC risk regardless of ER expression may be related to inherent differences in the biology and natural history of IBC vs non-IBC tumors. Iwamoto et al. reported that the ER? IBC subtype may not demonstrate the favorable prognosis typically associated with ER? non-IBC [22, 23] .
Biological mechanisms through which absent or short duration of breast-feeding influences risk of IBC may be related to the effects of the microenvironment surrounding the tumor during development. Lack of breast-feeding may lead to the failure of progenitor cells in breast tissue to undergo terminal differentiation and apoptosis making the breast susceptible to carcinogenic insult [24] especially if it occurs earlier in life. Our result that lack of breast-feeding and early age at first pregnancy increase the risk of triplenegative IBC is consistent with those of Milikan et al. [12] and Trivers et al. [25] , but no association between the reproductive risk factors and triple-negative breast cancer has been observed in other studies [26] .
Our study had several limitations, some of which are inherent in a hospital-based case-control study design. For example, referral bias played a role in the high proportion of controls in our study who reported a family history of breast cancer, because healthy women seen at the cancer prevention center for breast cancer screening are at higher risk of breast cancer compared to women in the general population [27] . The cases and controls included in the study analysis may also not be reflective of the IBC and cancer-free patients seen at MD Anderson or the general population since they were not sampled at random. A proportion of IBC cases in our study were referred from outside the state of Texas, and ascertainment bias is unavoidable if the distribution of risk factors for IBC differs among women residing in different regions of the USA.
There are sparse data on risk factors for IBC subtypes defined using ER, PR, and HER2neu, and a strength of our hospital-based case-control study was the availability of these biomarkers for clinical care among a relatively large number of patients with IBC. We were unable to further classify the luminal tumors into surrogate categories for luminal A and luminal B due to incomplete data on proliferation markers [28] . Given the small sample size, we classified HER2neu? tumors regardless of ER and PR status. However, data show that incomplete hormone resistance occurs with co-expression of Her2 and ER, suggesting that there may be a shared etiological pathway [29] . It is possible that the lack of heterogeneity of the associations between risk factors and IBC subtypes could have been due to the limited power of the study and should be further assessed in larger studies.
The finding that smoking was associated with the luminal IBC subtype is intriguing as the epidemiological evidence that smoking is associated with specific breast cancer subtypes is limited. The Women's Health Initiative Cohort study approximated tumor subtype by ER and PR and HER2neu status and found that duration and intensity of smoking were positively associated with an increased risk of ER? but not with an increased risk of triple-negative breast cancer [30] . Whether smoking promotes the development of certain IBC subtypes due to its association with other breast cancer risk factors, e.g., lower BMI, higher alcohol consumption, and lower physical activity [31] , is an important area of investigation. Although we were not able to include information on other important breast cancer risk factors due to incomplete and/or missing data, e.g., oral contraceptives and hormone replacement therapy, the epidemiologic factors that were investigated represent the most comprehensive set published to date in the IBC literature with subtype information. The majority of cases and controls were white women, and therefore, we were unable to explore ethnic differences in the prevalence of risk factors.
In conclusion, high BMI was found to be strongly and significantly associated with an increased risk of IBC of any subtype. Given the rate of obesity in the USA [32] and corresponding increases in incidence of IBC over time [1] , research efforts should be focused on determining the biological mechanisms through which BMI may increase susceptibility to IBC. Other modifiable risk factors, e.g., age at first pregnancy, breast-feeding, and smoking history, appear to have similar associations with IBC subtypes as reported in the literature for non-IBC subtypes. Therefore, the opportunity may exist for the development of comprehensive subtype-specific prevention strategies to reduce the risk of both inflammatory and non-IBCs.
